Should You Expect Robust Growth Potential for Rhythm Pharmaceuticals (RYTM) Ahead?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.